OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review
Lauren Rice, Lisa Cannon, Navin Dadlani, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 2, pp. 505-526
Open Access | Times Cited: 14
Lauren Rice, Lisa Cannon, Navin Dadlani, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 2, pp. 505-526
Open Access | Times Cited: 14
Showing 14 citing articles:
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors
Antonia Manduca, Valeria Buzzelli, Alessandro Rava, et al.
Pharmacological Research (2024) Vol. 203, pp. 107176-107176
Open Access | Times Cited: 8
Antonia Manduca, Valeria Buzzelli, Alessandro Rava, et al.
Pharmacological Research (2024) Vol. 203, pp. 107176-107176
Open Access | Times Cited: 8
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 19
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 19
Molecular Pathways, Neural Circuits and Emerging Therapies for Self-Injurious Behaviour
Kristina Zhang, George M. Ibrahim, Flavia Venetucci Gouveia
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1938-1938
Open Access
Kristina Zhang, George M. Ibrahim, Flavia Venetucci Gouveia
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1938-1938
Open Access
A Systems Biology Approach for Prioritizing ASD Genes in Large or Noisy Datasets
Veronica Remori, Heather Bondi, Mario Airoldi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2078-2078
Open Access
Veronica Remori, Heather Bondi, Mario Airoldi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2078-2078
Open Access
Formulation and Evaluation of Solid Self-Nanoemulsifying Drug Delivery System of Cannabidiol for Enhanced Solubility and Bioavailability
Fengying Wu, Qing Ma, Guanghui Tian, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 340-340
Open Access
Fengying Wu, Qing Ma, Guanghui Tian, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 340-340
Open Access
BEHAVIORAL AND TRANSCRIPTOMIC EFFECTS OF A NOVEL CANNABINOID ON A RAT VALPROIC ACID MODEL OF AUTISM
Sally Loomis, Dylan E. Da Silva, Ranjev Savopoulos, et al.
Neuropharmacology (2025), pp. 110450-110450
Closed Access
Sally Loomis, Dylan E. Da Silva, Ranjev Savopoulos, et al.
Neuropharmacology (2025), pp. 110450-110450
Closed Access
Personalized repetitive transcranial magnetic stimulation guided by the spectral electroencephalogram may enhance and democratize therapy for autism spectrum disorder
Milan Makale, Kenneth Blum, Abdalla Bowirrat, et al.
Medical Hypotheses (2024) Vol. 186, pp. 111333-111333
Closed Access | Times Cited: 2
Milan Makale, Kenneth Blum, Abdalla Bowirrat, et al.
Medical Hypotheses (2024) Vol. 186, pp. 111333-111333
Closed Access | Times Cited: 2
Medical use of cannabis and psychedelics in treating symptoms of mental disorders among military and veteran populations: A systematic review
Houyu Zhao, Kun Liang, Yiqun Fang
Theoretical and Natural Science (2024) Vol. 32, Iss. 1, pp. 298-312
Closed Access
Houyu Zhao, Kun Liang, Yiqun Fang
Theoretical and Natural Science (2024) Vol. 32, Iss. 1, pp. 298-312
Closed Access
Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis
Ibrahim Serag, Mona Mahmoud Elsakka, Mostafa Hossam El Din Moawad, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 10, pp. 1483-1493
Open Access
Ibrahim Serag, Mona Mahmoud Elsakka, Mostafa Hossam El Din Moawad, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 10, pp. 1483-1493
Open Access
Pharmacological and physiological effects of cannabidiol: a dose escalation, placebo washout study protocol
J. Patrick Neary, Jyotpal Singh, Jane Alcorn, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access
J. Patrick Neary, Jyotpal Singh, Jane Alcorn, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access
Cannabinoids for treating psychiatric disorders in youth: a systematic review of randomized controlled trials
Patrick Köck, Andrzej Badek, Maximilian Meyer, et al.
Child and Adolescent Psychiatry and Mental Health (2024) Vol. 18, Iss. 1
Open Access
Patrick Köck, Andrzej Badek, Maximilian Meyer, et al.
Child and Adolescent Psychiatry and Mental Health (2024) Vol. 18, Iss. 1
Open Access
Role of peroxisome proliferator-activated receptors α and γ in mediating the beneficial effects of β-caryophyllene in a rat model of fragile X syndrome
Alessandro Rava, Valeria Buzzelli, Alessandro Feo, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111234-111234
Open Access
Alessandro Rava, Valeria Buzzelli, Alessandro Feo, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111234-111234
Open Access
Safety and efficacy of orally administered full-spectrum medicinal cannabis plant extract 0.08% THC (NTI-164) in children with autism spectrum disorder: An open-label study
Dima El-Sukkari, Kanan Sharma, Bobbi Fleiss, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Dima El-Sukkari, Kanan Sharma, Bobbi Fleiss, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
